Combinatorial immunotherapies overcome MYC-driven immune evasion in triple negative breast cancer.
Lee JV, Housley F, Yau C, Nakagawa R, Winkler J, Anttila JM, Munne PM, Savelius M, Houlahan KE, Van de Mark D, Hemmati G, Hernandez GA, Zhang Y, Samson S, Baas C, Kok M, Esserman LJ, van 't Veer LJ, Rugo HS, Curtis C, Klefström J, Matloubian M, Goga A.
Lee JV, et al. Among authors: van de mark d.
Nat Commun. 2022 Jun 27;13(1):3671. doi: 10.1038/s41467-022-31238-y.
Nat Commun. 2022.
PMID: 35760778
Free PMC article.